Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jessica E. Harbison
Observed names:
Harbison, Jessica Emily,
JESSICA E. HARBISON,
Jessica E Harbison,
Jessica Harbison
Institutions:
Women's and Children's Hospital,
Women's and Children's Health Network,
Adelaide University,
The University of Adelaide
Observed institutions:
The University of Melbourne,
Women's and Children's Hospital,
St Vincent's Hospital Melbourne,
Women's and Children's Health Network,
Adelaide University,
The University of Adelaide,
St Vincents Institute of Medical Research
show all 7
ORCID:
0000-0002-1438-598X
Observed ORCID:
0000-0002-1438-598X
OpenAlex ID:
A5016652491
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
2023
·
Michaela Waibel
, John M. Wentworth
, et al.
·
New England Journal of Medicine
·
212
Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study
2019
·
Jessica E. Harbison
, Alexandra J. Roth‐Schulze
, et al.
·
Pediatric Diabetes
·
162
PDF
Parallel recovery of chromatin accessibility and gene expression dynamics from frozen human regulatory T cells
2023
·
Ying Y. Wong
, Jessica E. Harbison
, et al.
·
Scientific Reports
·
30
PDF
Cytotoxicity-Related Gene Expression and Chromatin Accessibility Define a Subset of CD4+ T Cells That Mark Progression to Type 1 Diabetes
2022
·
Naiara G. Bediaga
, Alexandra L. Garnham
, et al.
·
Diabetes
·
17
PDF
Associations between diet, the gut microbiome and short chain fatty acids in youth with islet autoimmunity and type 1 diabetes
2021
·
Jessica E. Harbison
, Rebecca L. Thomson
, et al.
·
Pediatric Diabetes
·
17
Gut Microbiome Dysbiosis and Increased Intestinal Permeability in Australian Children with Islet Autoimmunity and Type 1 Diabetes
2018
·
JESSICA E. HARBISON
, ALEXANDRA J. ROTH-SCHULZE
, et al.
·
Diabetes
·
4
β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes
2026
·
Michelle So
, Michaela Waibel
, et al.
·
Diabetes Care
·
1
Beta cell function and diabetes outcomes one year after stopping oral baricitinib immunotherapy for type 1 diabetes
2026
·
Michelle So
, Michaela Waibel
, et al.
Beta cell function and diabetes outcomes one year after stopping oral baricitinib immunotherapy for type 1 diabetes
2026
·
Michelle So
, Michaela Waibel
, et al.
Integrative epigenomic and transcriptomic profiling reveals dysregulated T cell regulatory networks in Stage 3 Type 1 diabetes
2026
·
Ying Y Wong
, Jessica E Harbison
, et al.
·
Research Square
PDF
ZEB2 orchestrates a transcriptional program to safeguard the integrity of human CD4+ Th1 effector memory cells
2026
·
Soon W Wong
, Christopher M Hope
, et al.
·
The Journal of Immunology
Cytotoxicity-related Gene Expression and Chromatin Accessibility Define a Subset of CD4+ T Cells that Mark Progression to Type 1 Diabetes
2022
·
Naiara G. Bediaga
, Alexandra L. Garnham
, et al.
Show more works
View as search
Works count:
13
Citation count:
443
H-index:
5
I10-index:
5
Year
Topic
Type